These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 5935423

  • 1. Effect of glucocorticoids on plasma insulin.
    Perley M, Kipnis DM.
    N Engl J Med; 1966 Jun 02; 274(22):1237-41. PubMed ID: 5935423
    [No Abstract] [Full Text] [Related]

  • 2. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.
    Perley M, Kipnis DM.
    Diabetes; 1966 Dec 02; 15(12):867-74. PubMed ID: 5957477
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL, Nakasone K, Pasternak K.
    Horm Metab Res; 1970 Jan 02; 2(1):6-8. PubMed ID: 5520756
    [No Abstract] [Full Text] [Related]

  • 8. [The behaviour of the serum insulin level in non obese adult diabetics after intravenous glucose, tolbutamide and glucagon].
    Lawecki J, Rogala H, Czyzyk A, Kowalski H.
    Acta Diabetol Lat; 1970 Jan 02; 7(3):407-20. PubMed ID: 5515384
    [No Abstract] [Full Text] [Related]

  • 9. [Inhibition of the insulo-pancreatic response to intravenous glucose and tolbutamide administration during infusion of epinephrine].
    Laudicina E, Bompiani G, Angileri G, Mancuso L.
    Folia Endocrinol; 1967 Apr 02; 20(2):154-63. PubMed ID: 4864821
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.
    Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Ostenson CG, Gustafsson J, Efendic S, Okret S.
    J Clin Invest; 1997 Oct 15; 100(8):2094-8. PubMed ID: 9329975
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Variations of insulinemia and glycemia compared in the course of an intravenous tolbutamide test in 29 persons].
    Vague J, Depieds R, Codaccioni JL, Vague P, Boeuf G.
    Bull Mem Soc Med Hop Paris; 1965 Oct 29; 116(13):Suppl:1367-81. PubMed ID: 5859607
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Critical considerations regarding the obesity-hyperinsulinism concept].
    Melani F.
    Acta Diabetol Lat; 1968 Oct 29; 5 Suppl 1():332-40. PubMed ID: 4907222
    [No Abstract] [Full Text] [Related]

  • 18. Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
    Feldman JM, Bivens CH, Skyler JS, Lebovitz HE.
    Horm Metab Res; 1975 Jul 29; 7(4):279-83. PubMed ID: 1150128
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.